Operating Margin in % of Cartesian Therapeutics, Inc. from 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Operating Margin history and change rate from 2014 to Q3 2025.
  • Cartesian Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -8.39K %.
  • Cartesian Therapeutics, Inc. annual Operating Margin for 2024 was -113 %, a 66.1% increase from 2023.
  • Cartesian Therapeutics, Inc. annual Operating Margin for 2023 was -332 %.
  • Cartesian Therapeutics, Inc. annual Operating Margin for 2017 was -30.8K %, a 7084% decline from 2016.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Cartesian Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -8.39K 01 Jul 2025 30 Sep 2025
Q2 2025 -8.58K 01 Apr 2025 30 Jun 2025
Q1 2025 -153 01 Jan 2025 31 Mar 2025
Q4 2024 -113 01 Oct 2024 31 Dec 2024
Q1 2018 -92.6K -91.9K -13256% 01 Jan 2018 31 Mar 2018
Q4 2017 -30.8K -30.4K -7084% 01 Oct 2017 31 Dec 2017
Q3 2017 -1.87K 01 Jul 2017 30 Sep 2017
Q2 2017 -1.26K 01 Apr 2017 30 Jun 2017
Q1 2017 -693 01 Jan 2017 31 Mar 2017
Q4 2016 -429 01 Oct 2016 31 Dec 2016

Cartesian Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -113 +220 +66.1% 01 Jan 2024 31 Dec 2024
2023 -332 01 Jan 2023 31 Dec 2023
2017 -30.8K -30.4K -7084% 01 Jan 2017 31 Dec 2017
2016 -429 -7.96 -1.89% 01 Jan 2016 31 Dec 2016
2015 -421 +85.6 +16.9% 01 Jan 2015 31 Dec 2015
2014 -507 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.